Healthy Volunteers 1CVS4

You may qualify and be compensated up to $3,400 for participating in this study if you meet the following criteria:

• Males and females from 18 to 55 years
• Non-smokers and moderate smokers (no more than 4 cigarettes or equivalent per day)
• Weight over 110 pounds and BMI between 18 and 34 kg/m2 (use the BMI calculator below)
• No medications (prescribed or over the counter) within 15 days before first dosing and during the study (except paracetamol, contraceptives, and Hormonal Replacement Therapy)

Next check-in dates: click here for the study calendars.

For more information, contact our recruiters at 844 246 8459 or email us at recruitment@biotrial.us

Study design: a screening visit and 2 identical periods separated by approximately 2 to 3 weeks, including one inpatient stay of 3 days & 3 nights (D-1 morning to D3 morning) and one visit on D6 (a phone call on period 1 and an OPV on-site on period 2).

Refer a friend: earn up to $100 when your friend participates in this study.

Study objective: testing an investigational drug for treating systolic heart failure, including safety, tolerability, and pharmacokinetics (how long it takes to leave the human body).

What is a systolic heart failure? People with systolic heart failure have a weak heart because their left ventricle, which pumps most of the blood, cannot contract (squeeze) normally when the heart beats. Heart failure is a major public health problem, with a prevalence of over 5.8 million in the USA and over 23 million worldwide.